Liraglutide API Product Introduction

Chemical & Physical Properties

Overview

Liraglutide, with the CAS Number 204656 - 20 - 2, is a highly regarded active pharmaceutical ingredient (API) that has transformed the treatment landscape for metabolic disorders. As a synthetic analog of human glucagon - like peptide - 1 (GLP - 1), it plays a pivotal role in developing medications that effectively manage type 2 diabetes and obesity, offering significant benefits to patients worldwide.

Properties

Liraglutide API typically presents as a white to off - white solid powder. It exhibits specific solubility properties, showing good solubility in aqueous solutions under appropriate pH conditions. This solubility characteristic is crucial for formulating various pharmaceutical dosage forms, such as injectables, ensuring the smooth and efficient manufacturing of final drug products. Under proper storage conditions, usually at 2 - 8°C, the powder maintains excellent stability, preserving its chemical and physical properties over time. This stability guarantees consistent quality in the manufacturing process and reliable performance in the end - user products.

Product Highlights

1. Glucose - Dependent Insulin Regulation for Precise Blood Sugar Control

Liraglutide stands out with its unique glucose - dependent insulin - releasing mechanism. By mimicking the actions of GLP - 1, it stimulates insulin secretion only when blood glucose levels are elevated, effectively reducing the risk of hypoglycemia, a common side effect of many traditional diabetes medications. This targeted approach ensures precise blood sugar regulation, helping patients maintain stable glucose levels throughout the day. Moreover, Liraglutide also slows down gastric emptying and suppresses appetite, further contributing to better blood sugar management and promoting weight loss. For pharmaceutical companies, this precise and safe mechanism allows for the development of highly effective diabetes and weight - management drugs, giving them a competitive edge in the market.

2. Versatile Clinical Applications for Multiple Health Conditions

Liraglutide is not only a cornerstone in the treatment of type 2 diabetes but also has demonstrated remarkable efficacy in managing obesity. Approved for both indications, it offers a dual - benefit solution, addressing two major global health challenges simultaneously. In diabetes treatment, it significantly reduces HbA1c levels, improving long - term glycemic control and reducing the risk of diabetes - related complications. For obesity, it helps patients achieve substantial and sustainable weight loss, enhancing their overall health and quality of life. Additionally, ongoing research is exploring its potential applications in other conditions, such as non - alcoholic fatty liver disease, expanding its clinical utility even further. This versatility makes Liraglutide API an attractive choice for pharmaceutical developers aiming to create multi - indication drugs and reach a broader patient population.

3. Established Market Presence and Growth Potential

With its proven efficacy and safety, Liraglutide has already established a strong presence in the global pharmaceutical market. The increasing prevalence of type 2 diabetes and obesity worldwide continues to drive the demand for Liraglutide - based medications. As more patients seek effective treatment options, and with the potential for new indications emerging from research, the market for Liraglutide API is set to grow steadily.partnering with us for Liraglutide API provides an excellent opportunity to tap into this expanding market. Whether it's for developing branded drugs, generic formulations, or for contract manufacturing, Liraglutide API offers a reliable and profitable business prospect in the dynamic pharmaceutical industry.

Quality Assurance

Our Liraglutide API is manufactured in state - of - the - art facilities that adhere rigorously to international Current Good Manufacturing Practice (cGMP) standards. A comprehensive quality control system is in place throughout the production process, from the sourcing of raw materials to the final packaging of the product. Advanced analytical techniques, including high - performance liquid chromatography (HPLC) and mass spectrometry, are used to ensure the API's high purity (≥ [99]%), consistent potency, and stability. Our commitment to quality ensures that you receive a top - notch product that meets and exceeds the strictest regulatory requirements globally, providing a solid foundation for your pharmaceutical manufacturing and business success.

Application Areas

Primarily used in the development and production of medications for the treatment of type 2 diabetes and obesity. Also serves as a key ingredient in research and development for potential new indications related to metabolic disorders. Ideal for pharmaceutical companies involved in drug discovery, development, and manufacturing, as well as contract manufacturing organizations (CMOs) looking to add high - demand and high - quality APIs to their product portfolios.

Storage Conditions

Store Liraglutide API in a cool, dry place at 2 - 8°C, away from direct light. Keep the container tightly sealed to prevent moisture absorption and contamination, ensuring the long - term stability and quality of the product.

If you have any questions or require further information about our Liraglutide API, please do not hesitate to contact us. Our dedicated team of experts is ready to assist you and explore potential business collaborations to drive success in the pharmaceutical market.